Endpoints: types, selection, interpretation of the results obtained on the example of cardiology studies by A. R. Navasardyan, S. Yu. Martsevich

Subjects: “…endpoints…”
Get full text

Rehabilitation of COVID-19 convalescents and its impact on cardiovascular endpoints: propensity score matching analysis by G. Kh. Lasynova, I. A. Lakman, D. F. Gareeva, A. A. Agapitov, L. F. Sadikova, А. R. Sakhautdinov, V. N. Pavlov, N. Sh. Zagidullin

Subjects: Get full text

Integrated Analysis of Metabolites and Biological Endpoints Bring New Insights into Sulfamethoxazole Stress Tolerance in Ryegrass by Yong Yang, Jiangtao Jia, Tao Han, Heng Zhang, Yvjie Wang, Luying Shao, Xinyi Wang

Subjects: “…biological endpoints…”
Get full text

Evaluation of the effectiveness of lipid-lowering agents by V. G. Shevko, M. A. Galas, T. L. Galankin, A. S. Kolbin

Subjects: Get full text

FIVE YEAR PROGNOSIS IN PATIENTS WITH CORONARY HEART DISEASE AND COMORBIDITIES: DATA FROM MULTICENTER STUDY IN INGUSHETIA REPUBLIC by P. O. Ugurchieva, R. T. Didigova, Z. O. Ugurchieva, M. N. Mamedov

Subjects: Get full text

Special Welfare and Ethical Requirements for Infectious Animal Experiments by MIN Fangui, FU Hongkun, LIU Yonggang, LIU Xiangmei, LIU Zhonghua, LI Yao, TAO Yufeng

Subjects: Get full text

New Approach Methodologies: Physiological Responses of Daphnids to Pharmaceutical Mixtures by Emma Rowan, Anne Leung, Katie O‘Rourke, Konstantinos Grintzalis

Subjects: Get full text

Facilities of diagnosis and monitoring of optic neuropathy in primary open-angle glaucoma. Part 1 by O. A. Kiseleva, N. V. Balatskaya, A. M. Bessmertny, V. I. Kotelin

Subjects: Get full text

Surrogate endpoints in cost-effectiveness analysis for use in medical technology assessment by T. I. Busheva, A. R. Kasimova, A. S. Kolbin, A. N. Pshenichnikov

Subjects: Get full text

Analyzing MASLD interventional clinical trial registration based on the ClinicalTrials.gov database by Hui Du, Jihan Huang, Youhua Wang, Chunyan Wang, Yiqun Wang, Luming Hou, Yali Li, Ying Li, Qianmin Su

Subjects: Get full text

Characterizing circulating biomarkers for childhood dementia disorders: A scoping review of clinical trials by Arlene D'Silva, James Barnes, Jason Djafar, Kaustuv Bhattacharya, Jingya Yan, Shekeeb Mohammad, Sushil Bandodkar, Alexandra Johnson, Michel Tchan, Christina Miteff, Kristina L. Elvidge, Russell C. Dale, Michelle Farrar

Subjects: Get full text

Surrogate endpoints for neonatal outcome: A rapid review by Shiraz El Adam, Karissa Johnston, Maanasa Venkataraman, Vanessa Perez Patel

Subjects: Get full text

Challenges and opportunities of predicting overall survival benefit from improvements to recurrence-free survival in stage II/III melanoma: a correlation meta-analysis by L. Leung, J.M. Kirkwood, S. Srinivasan, M. Dyer, A. Qian, M.-M. Pourrahmat, E. Kasireddy, J.R. May, A. Moshyk, M. Kurt

Subjects: “…surrogate endpoints…”
Get full text

Survival prognosis in individuals with a high spatial QRS-T angle by G. A. Muromtseva, E. B. Yarovaya, V. A. Kutsenko, E. A. Aidu, A. V. Kapustina, V. G. Trunov, Yu. A. Balanova, A. Yu. Efanov, S. A. Shalnova

Subjects: Get full text

WHO Workshop Report: Regulatory Science to Inform Clinical Pathways for Shigella Vaccines Intended for Use in Children in Low- and Middle-Income Countries by Robert W. Kaminski, Patricia B. Pavlinac, James A. Platts-Mills, Elizabeth T. Rogawski McQuade, William P. Hausdorff, Richard A. Isbrucker, Kirsten S. Vannice, Marco Cavaleri, Sonali Kochhar, Kirsty Mehring-LeDoare, Godwin Enwere, Annelies Wilder-Smith, Karen L. Kotloff, Samba Sow, Birgitte K. Giersing

Subjects: Get full text

Progression-free survival versus post-progression survival and overall survival in WHO grade 2 gliomas by Lisa Millgård Sagberg, Øyvind Salvesen, Asgeir Store Jakola, Erik Thurin, Eddie de Dios, Noah L.A. Nawabi, John L. Kilgallon, Joshua D. Bernstock, Vasileios K. Kavouridis, Timothy R. Smith, Ole Solheim

Subjects: Get full text

Artificial Intelligence-Driven Drug Toxicity Prediction: Advances, Challenges, and Future Directions by Ruiqiu Zhang, Hairuo Wen, Zhi Lin, Bo Li, Xiaobing Zhou

Subjects: Get full text

Sarcopenia in Ageing and Chronic Illness: Trial Endpoints and Regulatory Issues by Stephan vonHaehling, Henning T. Langer, Steven B. Heymsfield, William J. Evans, Stefan D. Anker

Subjects: Get full text

Identification and prioritisation of biomarkers of organophosphorus compounds-induced neurotoxicity by Antonio F. Hernández, Marina Lacasaña, Helena Garcia-Cortés, Mariana F. Fernández, Beatriz Gozález-Alzaga

Subjects: Get full text

Considerations for drug trials in hypertrophic cardiomyopathy by John P. Farrant, Matthias Schmitt, Anna B. Reid, Clifford J. Garratt, William G. Newman, Aneil Malhotra, Rhys Beynon, Masliza Mahmod, Betty Raman, Robert M. Cooper, Dana Dawson, Thomas Green, Sanjay K. Prasad, Anvesha Singh, Susanna Dodd, Hugh Watkins, Stefan Neubauer, Christopher A. Miller

Subjects: Get full text